SHR banner small

HOME SHR HEART STUDIES SHR THYROID STUDIES SHR CANCER STUDIES SHR-FUNDED AKC/CHF STUDIES SHR INC DONATIONS CONFERENCE REPORTS HEALTH ARTICLES

How do
I donate samples
for Saluki studies?

 

Your tax-deductible donations, made payable to SHR Inc, should be sent to

MaryDee Sist DVM
1629 Meech Road
Williamston, MI 48895

517-655-1354
517-655-5551
Salukihealth@aol.com

New deal to spur diagnostic test for canine hemangiosarcoma
December 2008, Fort Collins, Colorado
A new diagnostic test to detect canine hemangiosarcoma is in the works through collaboration with Colorado State University (CSU) Research Foundation, NeoTREX and the Veterinary Diagnostic Institute (VDxI) of Irvine, Ca. Officials signed a license agreement this week to develop a biomarker assay to detect this form of cancer in dogs. The technology, co-invented by faculty at CSU's Animal Cancer Center, a member of CSU's Cancer Supercluster, and investigators at VDxI, will be used to detect levels of the enxyme thymidine kinase in dogs using a simple blood test, the university reports. VDxI, a reference laboratory, plans to develop the technology and co-market with another technology to detect lymphoma in dogs. NeoTREX is the enterprise arms of the Cancer Supercluster.

This is very exciting news and what everyone hoped would be the eventual outcome of hemangiosarcoma research. We must continue to support investigations through the submission of samples and funding to qualified researchers. Hopefully, developing, proving the diagnostic utility and implementing this test will proceed quickly, because it certainly could be of benefit to our Salukis.

I will be attending the AKC Canine Health Foundation "Genes, Dogs and Cancer: 5th International Canine Cancer Conference" in February and will find out what the leading cancer researchers think about the potential for this diagnostic test.

MaryDee Sist, DVM